Cargando…
Silencing PROK2 Inhibits Invasion of Human Cervical Cancer Cells by Targeting MMP15 Expression
Cervical cancer is the second most frequent type of gynecologic cancer worldwide. Prokineticin 2 (PROK2) is reported to be involved in tumor progression in some malignant tumors. However, the role of PROK2 in the development of cervical cancer remains unknown. Our results indicate that PROK2 is over...
Autores principales: | Wu, Min-Hua, Wu, Pei-Ru, Hsieh, Yi-Hsien, Lin, Chia-Liang, Liu, Chung-Jung, Ying, Tsung-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504693/ https://www.ncbi.nlm.nih.gov/pubmed/32887509 http://dx.doi.org/10.3390/ijms21176391 |
Ejemplares similares
-
Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling
por: Wu, Min-Hua, et al.
Publicado: (2017) -
The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1(No correlation coefficient between VEGF and PROK1)
por: Goi, Takanori, et al.
Publicado: (2015) -
Prokineticin 2/PROK2 and Male Infertility
por: Petrella, Carla, et al.
Publicado: (2022) -
MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis
por: Lin, Chia-Liang, et al.
Publicado: (2021) -
PROK2/PROKR2 Signaling and Kallmann Syndrome
por: Dodé, Catherine, et al.
Publicado: (2013)